The need to move beyond a point-solutions approach to one built around applications designed to manage the end-to-end clinical trial process is crucial.
Jennifer Goldsmith
Advertisement
Jennifer Goldsmith is vice-president of Vault at Veeva Systems.
Articles by Jennifer Goldsmith
While launching a new clinical study is an exciting stage of product development for trial personnel, road blocks can emerge. A new approach is needed to cope with the volume of activates required for the study product registration.
Advertisement
Latest Updated Articles
- A New Approach to an Old Problem – Speeding Study Startup
Published: June 2nd 2016 | Updated:
It’s Time to Transform Clinical Trial OperationsPublished: August 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Building Broader Investigator Networks to Advance Global Breast Cancer Research
3
AI Offers New Pathways to Strengthen Site Leadership in Underserved Regions
4
dashClinical: Real-Time Participant Payments
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
